Multi StemCell Buat Duit Dengan Teknologi Baru

Multi StemCell Buat Duit Dengan Teknologi Baru

Multi Stemcell Bakal Meletup Sekarang

MultiStem Programs

MultiStem Overview

We are developing MultiStem®, our proprietary stem cell product for the treatment of diseases and conditions in the inflammatory and immune, neurological, and cardiovascular disease areas.  Working with independent clinical and research institutions in the United States and Europe, we have established clinical trials in each of these areas.   MultiStem is a biologic product that is manufactured from human stem cells obtained from adult bone marrow or other tissue sources. Unlike other cell types, after isolation from a qualified donor, MultiStem may be expanded on a large scale for future clinical use and stored in frozen form until needed. Cells obtained from a single donor require no genetic modification and may be used to produce banks yielding hundreds of thousands to millions of doses of MultiStem product – an amount far greater than other stem cell types can achieve. Each bank is extensively characterized to ensure product consistency and safety.

MultiStem consists of a special class of human stem cells that have the ability to express a range of therapeutically relevant proteins and other factors, as well as form a variety of cell types. Factors expressed by MultiStem have the potential to deliver therapeutic benefits, such as reducing inflammation, protecting damaged or injured tissue, and enhancing the formation of new blood vessels in regions of ischemic injury. These cells exhibit a “drug-like” profile in that they act primarily through the production of factors that regulate the immune system, protect damaged or injured cells, and promote tissue repair and healing. The cells are subsequently cleared from the body over time – much like a traditional drug or biologic treatment.